Anbio Biotechnology Cl A
(NNNN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||
| Net Income | 2,373 | 2,254 | 10,011 |
| Accounts receivable | 820 | -1,885 | 718 |
| Accounts payable and accrued liabilities | 798 | -581 | -482 |
| Other Working Capital | 45 | -1,204 | -5,530 |
| Other Operating Activity | -1,955 | 2,315 | -268 |
| Operating Cash Flow | $2,080 | $898 | $4,449 |
| Cash Flows From Investing Activities | |||
| Purchase Of Investment | -35,466 | -18,544 | -16,090 |
| Sale Of Investment | 35,803 | 20,274 | 14,562 |
| Investing Cash Flow | $337 | $1,730 | $-1,528 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | -345 | -43 | 0 |
| Financing Cash Flow | $-345 | $-43 | $N/A |
| Beginning Cash Position | 9,688 | 7,102 | 4,181 |
| End Cash Position | 11,761 | 9,688 | 7,102 |
| Net Cash Flow | $2,073 | $2,586 | $2,921 |
| Free Cash Flow | |||
| Operating Cash Flow | 2,080 | 898 | 4,449 |
| Free Cash Flow | 2,080 | 898 | 4,449 |